NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation today announced that it will report its first quarter 2018 financial and operating results on Wednesday, May 9, 2018.
Author: Business Wire
Global Femtosecond Laser Cataract Surgery Market Report 2018-2023: LENSAR Acquired the Laser Business Assets of Precision Eye Services Inc – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Femtosecond Laser Cataract Surgery Market – Segmented by Technology, Portability, Mode of Surgery, and Geography – Growth, Trends, and Forecast (2018 – 2023)” report has been added to ResearchAndMarkets.com’s offeri…
Global Femtosecond Laser Cataract Surgery Market Report 2018-2023: LENSAR Acquired the Laser Business Assets of Precision Eye Services Inc – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Femtosecond Laser Cataract Surgery Market – Segmented by Technology, Portability, Mode of Surgery, and Geography – Growth, Trends, and Forecast (2018 – 2023)” report has been added to ResearchAndMarkets.com’s offeri…
Ophthalmology Technology Summit 2018 Poised to Foster New Breakthroughs and Valuable Collaborations
ALISO VIEJO, Calif.–(BUSINESS WIRE)–OCTANe, Orange County’s technology and life sciences accelerator organization, today announced that it has partnered with the CEDARS/ASPENS Society to enhance offerings around ophthalmic surgery for its annual Ophthalmology Technology Summit (OTS). OTS 2018 will be held June 29 at the Fashion Island Hotel in Newport Beach, California, bringing together a high-powered lineup of leading ophthalmology technologists, researchers, clinicians and entrepreneurs in
Global Ophthalmic lasers Market 2017-2023: Market Influened by Ellex Medical Lasers, Optotek Medical, Abbott Medical Optics, Alcon Laboratories, Valeant Pharma – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic lasers Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic lasers market is e…
Aerie Pharmaceuticals Announces U.S. Launch of Rhopressa® (netarsudil ophthalmic solution) 0.02%
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that it has launched Rhopressa® in the United States. Rhopressa® is now in national and regional U.S. pharmaceutical distributors, and patients have access to Rhopressa® through their local pharmaci
4DMT and ROCHE Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products
EMERYVILLE, Calif.–(BUSINESS WIRE)–4D Molecular Therapeutics (4DMT), a leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development, today announced the expansion of its 2016 research a…
North America Fiber Optic Gyroscope Market Segmented By Sensing Axis, Device, Application, Geography & Company Landscape – Analysis, Trends & Forecast To 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Fiber Optic Gyroscope Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The North America fiberoptic gyroscope …
Ocular Therapeutix™ to Report First Quarter 2018 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report first quarter ended March 31, 2018 financial results on Tuesday, May 8, 2018. Following distribution of the earnings release via wire services, the Ocular Therapeutix management team will host a live conference call and webcast at 4:
Global Retinal Drugs Market – Development of Innovative Therapies to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)–#RareDiseases–Technavio’s latest market research report on the global retinal drugs market provides an analysis of the most important trends and drivers.
Ophthalmic Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global ophthalmic drugs market to grow wi…
Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), announced today that its first quarter 2018 financial results will be released after the market closes on Tuesday, May 8, 2018. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business update. The live webcast and a replay may be accessed by visiting the Company’s website at htt
Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), announced today that its first quarter 2018 financial results will be released after the market closes on Tuesday, May 8, 2018. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business update. The live webcast and a replay may be accessed by visiting the Company’s website at htt
BioTime to Announce First Quarter 2018 Results on May 10, 2018
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will release first quarter 2018 financial and operating results on Thursday, May 10, 2018, after the close of the U.S. financial markets. The Company will host a conference call and webcast on Thursday, May 10, 2018, at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time to discuss the results and recent corporate developments. The co
Global Conjunctivitis Market By Disease Type, Analysis, Trends, Market Size and Forecasts up to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Conjunctivitis Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023” report has been added to ResearchAndMarkets.com’s offering. The report on global conjunctivitis market provides qualitative and…
Global Vision Care Market 2018-2022: Rise in Product Launches Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The global vision care market to grow at a CAGR of 4.25% during the period 2018-2022. Global Vision Care Market 2018-2022, ha…
Samenvatting: Novaliq presenteert wetenschappelijk en klinisch onderzoek tijdens 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu
HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH, een gespecialiseerd farmaceutisch bedrijf met een revolutionair platform voor medicijntoediening dat slecht oplosbare geneesmiddelen verandert in effectieve oogheelkundige therapieën heeft vandaag aangekondigd dat vier wetenschappelijke posters zullen worden gepresenteerd op de bijeenkomst van de Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaïi (29 april- 3 mei). De verscheidenheid aan te presenteren gegevens wee
Samenvatting: Novaliq presenteert wetenschappelijk en klinisch onderzoek tijdens 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu
HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH, een gespecialiseerd farmaceutisch bedrijf met een revolutionair platform voor medicijntoediening dat slecht oplosbare geneesmiddelen verandert in effectieve oogheelkundige therapieën heeft vandaag aangekondigd dat vier wetenschappelijke posters zullen worden gepresenteerd op de bijeenkomst van de Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaïi (29 april- 3 mei). De verscheidenheid aan te presenteren gegevens wee
Resumen: Novaliq presentará datos de investigaciones científicas y clínicas en el Congreso de la Association for Research in Vision and Ophthalmology 2018 en Honolulu (Hawái)
HEIDELBERG, Alemania–(BUSINESS WIRE)–La investigación se centrará en la tecnología de administración de fármacos in agua EyeSol® de Novaliq Novaliq GmbH, una empresa de productos farmacéuticos especiales con una innovadora plataforma de administración de fármacos que transforma los fármacos poco solubles en terapias efectivas para oftalmología, ha anunciado que se presentarán cuatro posters científicos en el congreso de 2018 de la Association for Research in Vision and Ophthalmology (ARVO) en
Resumen: Novaliq presentará datos de investigaciones científicas y clínicas en el Congreso de la Association for Research in Vision and Ophthalmology 2018 en Honolulu (Hawái)
HEIDELBERG, Alemania–(BUSINESS WIRE)–La investigación se centrará en la tecnología de administración de fármacos in agua EyeSol® de Novaliq Novaliq GmbH, una empresa de productos farmacéuticos especiales con una innovadora plataforma de administración de fármacos que transforma los fármacos poco solubles en terapias efectivas para oftalmología, ha anunciado que se presentarán cuatro posters científicos en el congreso de 2018 de la Association for Research in Vision and Ophthalmology (ARVO) en